Violin Jonathan
SEC CIK 1730615 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.\DE | See Remarks, Dir | 480.9K | — | $6.11M | 9 | 2021-12-08 | 2023-02-02 |
Most active insiders at VRDN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fairmount Funds Management LLC | Dir, 10% | $20.00M | — |
| 2 | Fairmount Healthcare Fund II GP LLC | Dir, 10% | $10.00M | — |
| 3 | Tousignant Jennifer | CLO | — | $419.0K |
| 4 | Harmon Seth | CFO | — | — |
| 5 | Tripuraneni Radhika | Chief Medical Off | — | — |
| 6 | Mahoney Stephen F. | Pres, CEO, Dir | — | — |
| 7 | Beetham Thomas W. | COO | — | — |
Violin Jonathan made no open-market trades at VRDN in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2023-02-07 | 2023-02-02 | VRDN | Viridian Therapeutics, Inc.\DE | Violin Jonathan | CEO, Dir | S - Sale+OE | $36.80 | -50.0K | 480.9K | -9% | -$1.84M |
| DA | 2023-02-07 | 2023-02-02 | VRDN | Viridian Therapeutics, Inc.\DE | Violin Jonathan | CEO, Dir | M - OptEx | $0.15 | +50.0K | 530.9K | +10% | +$7,500 |
| 2023-02-03 | 2023-02-02 | VRDN | Viridian Therapeutics, Inc.\DE | Violin Jonathan | CEO, Dir | S - Sale | $36.80 | -50.0K | 430.9K | -10% | -$1.84M | |
| 2022-06-02 | 2022-06-01 | VRDN | Viridian Therapeutics, Inc.\DE | Violin Jonathan | CEO, Dir | S - Sale | $12.20 | -30.0K | 480.9K | -6% | -$366.0K | |
| 2022-05-04 | 2022-05-02 | VRDN | Viridian Therapeutics, Inc.\DE | Violin Jonathan | CEO, Dir | S - Sale | $13.04 | -30.0K | 510.9K | -6% | -$391.2K | |
| M | 2022-04-05 | 2022-04-01+ | VRDN | Viridian Therapeutics, Inc.\DE | Violin Jonathan | CEO, Dir | S - Sale | $18.92 | -30.0K | 540.9K | -5% | -$567.6K |
| M | 2022-03-03 | 2022-03-01+ | VRDN | Viridian Therapeutics, Inc.\DE | Violin Jonathan | CEO, Dir | S - Sale | $17.65 | -30.0K | 582.0K | -5% | -$529.5K |
| DM | 2022-02-03 | 2022-02-01+ | VRDN | Viridian Therapeutics, Inc.\DE | Violin Jonathan | CEO, Dir | S - Sale | $19.09 | -30.0K | 600.9K | -5% | -$572.8K |
| D | 2021-12-10 | 2021-12-08 | VRDN | Viridian Therapeutics, Inc.\DE | Violin Jonathan | See Remarks, Dir | C - Cnv Deriv | $0.00 | +627.6K | 630.9K | +18,784% | $0 |
Purchase Sale Sale after option exercise All abbreviations